8-K
filed May 2, 2025, 7:59 PM ET
ticker ZWS
CIK 0001439288
other
confidence high
sentiment neutral
materiality 0.30
Zurn Elkay shareholders approve 2.5M share increase to equity plan, elect four directors
Zurn Elkay Water Solutions Corp
- Shareholders approved 2,500,000 share increase to Performance Incentive Plan (98.1% for).
- Four directors elected to three-year terms: Bartlett, Butler, Jahnke, Longren (94.4%-98.4% for).
- Advisory say-on-pay passed with 70.7% of votes cast in favor.
- Ratification of Ernst & Young as auditor for FY2025 passed with 97.8% for.
- Total shares eligible to vote: 168,795,157 as of March 4, 2025.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001439288-25-000084
- form_type
- 8-K
- ticker
- ZWS
- cik
- 0001439288
- company_name
- Zurn Elkay Water Solutions Corp
- filed_at
- 2025-05-02T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:48.307209+00:00
- generated_at
- 2026-05-22T22:30:13.818476+00:00
- sec_items
- ["5.02", "5.07", "9.01"]
- event_type
- other
- sentiment
- neutral
- materiality_score
- 0.3
- calibrated_materiality_score
- 0.3
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001439288-25-000084
- json_url
- https://secwatch.observer/filing/0001439288-25-000084.json
- markdown_url
- https://secwatch.observer/filing/0001439288-25-000084.md
- text_url
- https://secwatch.observer/filing/0001439288-25-000084.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1439288/000143928825000084/0001439288-25-000084-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1439288/000143928825000084/zws-20250501.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
EDSA
Edesa Biotech shareholders approve equity plan amendment adding 750K shares
Edesa Biotech, Inc.
May 29, 2026, 4:15 PM ET
other
Items 5.02, 5.07, 9.01
same SEC item: 5.02, 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
HAFC
Director Gideon Yu resigns from Hanmi board; stockholders approve 2026 ESPP
HANMI FINANCIAL CORP
May 27, 2026, 6:15 PM ET
other
Items 5.02, 5.07, 9.01
same SEC item: 5.02, 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
XBP
XBP Global Holdings annual meeting elects directors, approves auditor and say-on-pay
XBP Global Holdings, Inc.
June 1, 2026, 5:00 PM ET
other
Items 5.07, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
AXON
Axon shareholders elect all 9 director nominees and approve say-on-pay at 2026 annual meeting
AXON ENTERPRISE, INC.
June 1, 2026, 4:10 PM ET
other
Items 5.07, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
NRGV
Energy Vault shareholders elect three Class II directors and ratify BDO USA as auditor
Energy Vault Holdings, Inc.
June 1, 2026, 11:36 AM ET
other
Items 5.07, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
RUN
Sunrun annual meeting elects nine directors, approves say-on-pay, ratifies auditor
Sunrun Inc.
May 29, 2026, 6:01 PM ET
other
Items 5.07, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
HSTM
HealthStream: annual meeting votes pass; directors elected, auditor ratified, say-on-pay approved
HEALTHSTREAM INC
May 29, 2026, 4:34 PM ET
other
Items 5.07, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
LIF
Life360 shareholders elect four directors, approve say-on-pay, ratify Deloitte at annual meeting
Life360, Inc.
May 29, 2026, 4:18 PM ET
other
Items 5.07, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.